GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) - Net Assets
Based on the latest financial reports, GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) has net assets worth CN¥1.72 Billion CNY (≈ $252.05 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.55 Billion ≈ $372.52 Million USD) and total liabilities (CN¥823.26 Million ≈ $120.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of GuangYuYuan Chinese Herbal Medicine Co L to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.72 Billion |
| % of Total Assets | 67.66% |
| Annual Growth Rate | 23.36% |
| 5-Year Change | -22.79% |
| 10-Year Change | -4.41% |
| Growth Volatility | 175.73 |
GuangYuYuan Chinese Herbal Medicine Co Ltd - Net Assets Trend (1993–2025)
This chart illustrates how GuangYuYuan Chinese Herbal Medicine Co Ltd's net assets have evolved over time, based on quarterly financial data. See 600771 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for GuangYuYuan Chinese Herbal Medicine Co Ltd (1993–2025)
The table below shows the annual net assets of GuangYuYuan Chinese Herbal Medicine Co Ltd from 1993 to 2025. For live valuation and market cap data, see 600771 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.65 Billion ≈ $241.89 Million |
+3.92% |
| 2024-12-31 | CN¥1.59 Billion ≈ $232.77 Million |
+5.49% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.65 Million |
-12.54% |
| 2022-12-31 | CN¥1.72 Billion ≈ $252.28 Million |
-19.47% |
| 2021-12-31 | CN¥2.14 Billion ≈ $313.27 Million |
-13.31% |
| 2020-12-31 | CN¥2.47 Billion ≈ $361.39 Million |
+1.14% |
| 2019-12-31 | CN¥2.44 Billion ≈ $357.31 Million |
+3.63% |
| 2018-12-31 | CN¥2.36 Billion ≈ $344.78 Million |
+18.99% |
| 2017-12-31 | CN¥1.98 Billion ≈ $289.76 Million |
+14.51% |
| 2016-12-31 | CN¥1.73 Billion ≈ $253.05 Million |
+134.59% |
| 2015-12-31 | CN¥737.13 Million ≈ $107.87 Million |
+760.64% |
| 2014-12-31 | CN¥85.65 Million ≈ $12.53 Million |
+16.28% |
| 2013-12-31 | CN¥73.65 Million ≈ $10.78 Million |
+43.04% |
| 2012-12-31 | CN¥51.49 Million ≈ $7.54 Million |
+107.85% |
| 2011-12-31 | CN¥-656.24 Million ≈ $-96.03 Million |
+21.60% |
| 2010-12-31 | CN¥-836.99 Million ≈ $-122.48 Million |
+18.51% |
| 2009-12-31 | CN¥-1.03 Billion ≈ $-150.30 Million |
-23.60% |
| 2008-12-31 | CN¥-831.01 Million ≈ $-121.60 Million |
+13.71% |
| 2007-12-31 | CN¥-963.09 Million ≈ $-140.93 Million |
-262.92% |
| 2006-12-31 | CN¥591.15 Million ≈ $86.50 Million |
+12.75% |
| 2005-12-31 | CN¥524.31 Million ≈ $76.72 Million |
+9.36% |
| 2004-12-31 | CN¥479.43 Million ≈ $70.15 Million |
+10.03% |
| 2003-12-31 | CN¥435.74 Million ≈ $63.76 Million |
+6.03% |
| 2002-12-31 | CN¥410.96 Million ≈ $60.14 Million |
+9.68% |
| 2001-12-31 | CN¥374.69 Million ≈ $54.83 Million |
+30.98% |
| 2000-12-31 | CN¥286.07 Million ≈ $41.86 Million |
+19.40% |
| 1999-12-31 | CN¥239.60 Million ≈ $35.06 Million |
+71.89% |
| 1998-12-31 | CN¥139.39 Million ≈ $20.40 Million |
+8.85% |
| 1997-12-31 | CN¥128.06 Million ≈ $18.74 Million |
+11.13% |
| 1996-12-31 | CN¥115.24 Million ≈ $16.86 Million |
+287.85% |
| 1995-12-31 | CN¥29.71 Million ≈ $4.35 Million |
+382.42% |
| 1994-12-31 | CN¥6.16 Million ≈ $901.23K |
+208.10% |
| 1993-12-31 | CN¥2.00 Million ≈ $292.51K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GuangYuYuan Chinese Herbal Medicine Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 105439.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥2.10 Billion | 128.86% |
| Total Equity | CN¥1.63 Billion | 100.00% |
GuangYuYuan Chinese Herbal Medicine Co Ltd Competitors by Market Cap
The table below lists competitors of GuangYuYuan Chinese Herbal Medicine Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NanJi ECommerce Co Ltd
SHE:002127
|
$966.31 Million |
|
Mcmillan Shakespeare Ltd
AU:MMS
|
$966.81 Million |
|
Gui Zhou Tyre Co Ltd
SHE:000589
|
$966.83 Million |
|
GuangDong Leary New Material Technology Co. Ltd. A
SHG:688683
|
$966.99 Million |
|
Arafura Rare EARTHS Ltd
AU:ARU
|
$966.23 Million |
|
CHERVON HOLDINGS LTD
F:AZ9
|
$965.89 Million |
|
Prosiebensat 1 Media AG
XETRA:PSM
|
$965.79 Million |
|
Morguard Corporation
TO:MRC
|
$965.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GuangYuYuan Chinese Herbal Medicine Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,569,808,332 to 1,632,668,553, a change of 62,860,221 (4.0%).
- Net income of 63,043,503 contributed positively to equity growth.
- Dividend payments of 1,191,540 reduced retained earnings.
- Other comprehensive income decreased equity by 484,516,347.
- Other factors increased equity by 485,524,605.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥63.04 Million | +3.86% |
| Dividends Paid | CN¥1.19 Million | -0.07% |
| Other Comprehensive Income | CN¥-484.52 Million | -29.68% |
| Other Changes | CN¥485.52 Million | +29.74% |
| Total Change | CN¥- | 4.00% |
Book Value vs Market Value Analysis
This analysis compares GuangYuYuan Chinese Herbal Medicine Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.04x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1795.96x to 4.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | CN¥0.01 | CN¥13.49 | x |
| 1994-12-31 | CN¥0.02 | CN¥13.49 | x |
| 1995-12-31 | CN¥0.11 | CN¥13.49 | x |
| 1996-12-31 | CN¥0.43 | CN¥13.49 | x |
| 1997-12-31 | CN¥0.48 | CN¥13.49 | x |
| 1998-12-31 | CN¥0.52 | CN¥13.49 | x |
| 1999-12-31 | CN¥0.90 | CN¥13.49 | x |
| 2000-12-31 | CN¥1.10 | CN¥13.49 | x |
| 2001-12-31 | CN¥1.25 | CN¥13.49 | x |
| 2002-12-31 | CN¥1.36 | CN¥13.49 | x |
| 2003-12-31 | CN¥1.51 | CN¥13.49 | x |
| 2004-12-31 | CN¥1.52 | CN¥13.49 | x |
| 2005-12-31 | CN¥1.65 | CN¥13.49 | x |
| 2006-12-31 | CN¥1.71 | CN¥13.49 | x |
| 2007-12-31 | CN¥-3.26 | CN¥13.49 | x |
| 2008-12-31 | CN¥-2.77 | CN¥13.49 | x |
| 2009-12-31 | CN¥-3.34 | CN¥13.49 | x |
| 2010-12-31 | CN¥-2.74 | CN¥13.49 | x |
| 2011-12-31 | CN¥-1.97 | CN¥13.49 | x |
| 2012-12-31 | CN¥0.06 | CN¥13.49 | x |
| 2013-12-31 | CN¥0.14 | CN¥13.49 | x |
| 2014-12-31 | CN¥0.25 | CN¥13.49 | x |
| 2015-12-31 | CN¥2.52 | CN¥13.49 | x |
| 2016-12-31 | CN¥4.37 | CN¥13.49 | x |
| 2017-12-31 | CN¥3.87 | CN¥13.49 | x |
| 2018-12-31 | CN¥6.48 | CN¥13.49 | x |
| 2019-12-31 | CN¥4.82 | CN¥13.49 | x |
| 2020-12-31 | CN¥4.93 | CN¥13.49 | x |
| 2021-12-31 | CN¥4.29 | CN¥13.49 | x |
| 2022-12-31 | CN¥3.48 | CN¥13.49 | x |
| 2023-12-31 | CN¥2.99 | CN¥13.49 | x |
| 2024-12-31 | CN¥3.16 | CN¥13.49 | x |
| 2025-12-31 | CN¥3.34 | CN¥13.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GuangYuYuan Chinese Herbal Medicine Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.60%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.49x
- Recent ROE (3.86%) is below the historical average (61.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 136.57% | 14.24% | 0.71x | 13.43x | CN¥2.53 Million |
| 1994 | 47.97% | 9.91% | 0.61x | 7.87x | CN¥2.34 Million |
| 1995 | 35.85% | 14.72% | 0.76x | 3.19x | CN¥7.68 Million |
| 1996 | 10.36% | 14.37% | 0.43x | 1.66x | CN¥420.22K |
| 1997 | 10.01% | 10.53% | 0.43x | 2.22x | CN¥18.50K |
| 1998 | 8.13% | 8.69% | 0.44x | 2.13x | CN¥-2.61 Million |
| 1999 | 11.97% | 12.07% | 0.64x | 1.54x | CN¥4.72 Million |
| 2000 | 18.19% | 17.09% | 0.47x | 2.26x | CN¥23.93 Million |
| 2001 | 13.43% | 10.04% | 0.44x | 3.02x | CN¥11.43 Million |
| 2002 | 10.26% | 7.38% | 0.43x | 3.26x | CN¥939.49K |
| 2003 | 7.08% | 5.08% | 0.26x | 5.38x | CN¥-11.72 Million |
| 2004 | 7.45% | 5.34% | 0.26x | 5.45x | CN¥-10.31 Million |
| 2005 | 8.02% | 6.43% | 0.23x | 5.42x | CN¥-8.73 Million |
| 2006 | 4.60% | 3.34% | 0.24x | 5.68x | CN¥-24.54 Million |
| 2007 | 0.00% | -144.64% | 0.31x | 0.00x | CN¥-657.00 Million |
| 2008 | 0.00% | 93.25% | 0.23x | 0.00x | CN¥381.10 Million |
| 2009 | 0.00% | -58.01% | 0.22x | 0.00x | CN¥-34.45 Million |
| 2010 | 0.00% | 84.75% | 0.19x | 0.00x | CN¥287.65 Million |
| 2011 | 0.00% | 132.30% | 0.28x | 0.00x | CN¥367.20 Million |
| 2012 | 1676.45% | 136.42% | 0.36x | 34.00x | CN¥353.45 Million |
| 2013 | -41.22% | -7.30% | 0.51x | 11.09x | CN¥-24.31 Million |
| 2014 | 43.57% | 10.35% | 0.77x | 5.50x | CN¥28.24 Million |
| 2015 | 0.28% | 0.47% | 0.40x | 1.49x | CN¥-69.47 Million |
| 2016 | 7.19% | 13.11% | 0.44x | 1.25x | CN¥-48.01 Million |
| 2017 | 12.37% | 20.26% | 0.46x | 1.32x | CN¥45.42 Million |
| 2018 | 16.35% | 23.11% | 0.53x | 1.35x | CN¥145.35 Million |
| 2019 | 5.52% | 10.69% | 0.34x | 1.50x | CN¥-105.63 Million |
| 2020 | 1.33% | 2.88% | 0.29x | 1.57x | CN¥-209.21 Million |
| 2021 | -15.06% | -37.02% | 0.28x | 1.48x | CN¥-526.19 Million |
| 2022 | -14.69% | -22.11% | 0.42x | 1.60x | CN¥-420.19 Million |
| 2023 | 6.02% | 7.02% | 0.49x | 1.76x | CN¥-59.53 Million |
| 2024 | 4.74% | 6.10% | 0.54x | 1.45x | CN¥-82.53 Million |
| 2025 | 3.86% | 4.60% | 0.56x | 1.49x | CN¥-100.22 Million |
Industry Comparison
This section compares GuangYuYuan Chinese Herbal Medicine Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $3,454,789,497
- Average return on equity (ROE) among peers: 9.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GuangYuYuan Chinese Herbal Medicine Co Ltd (600771) | CN¥1.72 Billion | 136.57% | 0.48x | $966.26 Million |
| Zhejiang Int'L Group Co Ltd (000411) | $172.72 Million | 3.54% | 3.43x | $732.38 Million |
| Zhejiang Zhenyuan Share Co Ltd (000705) | $1.39 Billion | 4.40% | 0.48x | $308.51 Million |
| Hunan Jingfeng Pharmaceutical (000908) | $329.66 Million | 0.90% | 1.55x | $750.55 Million |
| Hubei Guangji Pharmaceutical Co Ltd (000952) | $481.54 Million | 6.36% | 0.40x | $302.41 Million |
| Yifan Xinfu Pharmaceutical Co Ltd (002019) | $320.93 Million | 6.38% | 0.61x | $1.73 Billion |
| Guangdong Jiaying Pharmaceutical Co Ltd (002198) | $82.63 Million | 26.76% | 0.45x | $247.30 Million |
| Sichuan Kelun Pharmaceutical Co Ltd (002422) | $26.74 Billion | 10.98% | 0.40x | $8.36 Billion |
| Chongqing Lummy Pharmaceutical (300006) | $1.69 Billion | 1.22% | 0.84x | $760.20 Million |
| Zhejiang Jolly Pharmaceutical Co Ltd (300181) | $2.76 Billion | 9.89% | 0.32x | $1.32 Billion |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) | $582.91 Million | 20.21% | 0.05x | $1.63 Billion |
About GuangYuYuan Chinese Herbal Medicine Co Ltd
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional Chinese medicine, fine Chinese medicine, and health wine. It provides its products in the form of pills, powders, tablets, hard capsules, granules, mixtures, and wine preparations. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its na… Read more